Cargando…

Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes

BACKGROUND: Abdominal obesity (AO) is linked to reduced health status and mortality. While it is known that AO is prevalent in chronic obstructive pulmonary disease (AO-COPD), the specific metabolic and functional consequences associated with AO-COPD remain understudied. METHODS: We studied 199 olde...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruthirds, Clayton L., Deutz, Nicolaas E. P., Mizubuti, Yani G. G., Harrykissoon, Rajesh I., Zachria, Anthony J., Engelen, Mariëlle P. K. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714145/
https://www.ncbi.nlm.nih.gov/pubmed/36457012
http://dx.doi.org/10.1186/s12986-022-00714-z
_version_ 1784842160144646144
author Cruthirds, Clayton L.
Deutz, Nicolaas E. P.
Mizubuti, Yani G. G.
Harrykissoon, Rajesh I.
Zachria, Anthony J.
Engelen, Mariëlle P. K. J.
author_facet Cruthirds, Clayton L.
Deutz, Nicolaas E. P.
Mizubuti, Yani G. G.
Harrykissoon, Rajesh I.
Zachria, Anthony J.
Engelen, Mariëlle P. K. J.
author_sort Cruthirds, Clayton L.
collection PubMed
description BACKGROUND: Abdominal obesity (AO) is linked to reduced health status and mortality. While it is known that AO is prevalent in chronic obstructive pulmonary disease (AO-COPD), the specific metabolic and functional consequences associated with AO-COPD remain understudied. METHODS: We studied 199 older adults with COPD and 168 control subjects with and without AO and assessed visceral adipose tissue (VAT) by dual-energy X-ray absorptiometry. VAT > 70th percentile of the control group qualified a subject as AO in a sex specific manner. We measured plasma concentrations and whole body production (WBP) rates of multiple amino acids to assess the metabolic profile. We assessed medical history, body composition by Dual-Energy X-ray Absorptiometry, muscle strength, and cognitive function. We performed statistics by analysis of covariance (p) and FDR (q) for multiple comparisons. RESULTS: AO-COPD subjects had 27% more VAT (q < 0.01) than AO-Control subjects despite correction for BMI. Branched-chain amino acid concentrations and WBP rates were generally elevated in AO-COPD but whole body clearance rate was only elevated in COPD. Metabolic syndrome comorbidities (p < 0.01) and systemic inflammation (P < 0.05) were most prevalent in the AO-COPD group. Muscle strength was reduced in COPD subjects (p < 0.001), but partially preserved when combined with AO. Cognitive dysfunction and mood disturbances were present in COPD subjects (p < 0.001) with worst performers in AO-COPD (q < 0.05). CONCLUSION: The presence of AO is associated with specific metabolic and functional phenotypes in COPD. Clinical trial registry Trial registration ClinicalTrials.gov. In the present paper, we report an analysis of the baseline measurements of COPD subjects and healthy controls from the study numbers: NCT01787682, NCT01787682, NCT02157844, NCT02082418, NCT02065141, NCT02770092, NCT02908425, NCT03159390, NCT02780219, NCT03327181, NCT03796455, NCT04928872, NCT04461236, NCT01173354, NCT01154400. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12986-022-00714-z.
format Online
Article
Text
id pubmed-9714145
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97141452022-12-02 Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes Cruthirds, Clayton L. Deutz, Nicolaas E. P. Mizubuti, Yani G. G. Harrykissoon, Rajesh I. Zachria, Anthony J. Engelen, Mariëlle P. K. J. Nutr Metab (Lond) Research BACKGROUND: Abdominal obesity (AO) is linked to reduced health status and mortality. While it is known that AO is prevalent in chronic obstructive pulmonary disease (AO-COPD), the specific metabolic and functional consequences associated with AO-COPD remain understudied. METHODS: We studied 199 older adults with COPD and 168 control subjects with and without AO and assessed visceral adipose tissue (VAT) by dual-energy X-ray absorptiometry. VAT > 70th percentile of the control group qualified a subject as AO in a sex specific manner. We measured plasma concentrations and whole body production (WBP) rates of multiple amino acids to assess the metabolic profile. We assessed medical history, body composition by Dual-Energy X-ray Absorptiometry, muscle strength, and cognitive function. We performed statistics by analysis of covariance (p) and FDR (q) for multiple comparisons. RESULTS: AO-COPD subjects had 27% more VAT (q < 0.01) than AO-Control subjects despite correction for BMI. Branched-chain amino acid concentrations and WBP rates were generally elevated in AO-COPD but whole body clearance rate was only elevated in COPD. Metabolic syndrome comorbidities (p < 0.01) and systemic inflammation (P < 0.05) were most prevalent in the AO-COPD group. Muscle strength was reduced in COPD subjects (p < 0.001), but partially preserved when combined with AO. Cognitive dysfunction and mood disturbances were present in COPD subjects (p < 0.001) with worst performers in AO-COPD (q < 0.05). CONCLUSION: The presence of AO is associated with specific metabolic and functional phenotypes in COPD. Clinical trial registry Trial registration ClinicalTrials.gov. In the present paper, we report an analysis of the baseline measurements of COPD subjects and healthy controls from the study numbers: NCT01787682, NCT01787682, NCT02157844, NCT02082418, NCT02065141, NCT02770092, NCT02908425, NCT03159390, NCT02780219, NCT03327181, NCT03796455, NCT04928872, NCT04461236, NCT01173354, NCT01154400. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12986-022-00714-z. BioMed Central 2022-12-01 /pmc/articles/PMC9714145/ /pubmed/36457012 http://dx.doi.org/10.1186/s12986-022-00714-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cruthirds, Clayton L.
Deutz, Nicolaas E. P.
Mizubuti, Yani G. G.
Harrykissoon, Rajesh I.
Zachria, Anthony J.
Engelen, Mariëlle P. K. J.
Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes
title Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes
title_full Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes
title_fullStr Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes
title_full_unstemmed Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes
title_short Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes
title_sort abdominal obesity in copd is associated with specific metabolic and functional phenotypes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714145/
https://www.ncbi.nlm.nih.gov/pubmed/36457012
http://dx.doi.org/10.1186/s12986-022-00714-z
work_keys_str_mv AT cruthirdsclaytonl abdominalobesityincopdisassociatedwithspecificmetabolicandfunctionalphenotypes
AT deutznicolaasep abdominalobesityincopdisassociatedwithspecificmetabolicandfunctionalphenotypes
AT mizubutiyanigg abdominalobesityincopdisassociatedwithspecificmetabolicandfunctionalphenotypes
AT harrykissoonrajeshi abdominalobesityincopdisassociatedwithspecificmetabolicandfunctionalphenotypes
AT zachriaanthonyj abdominalobesityincopdisassociatedwithspecificmetabolicandfunctionalphenotypes
AT engelenmariellepkj abdominalobesityincopdisassociatedwithspecificmetabolicandfunctionalphenotypes